Ceska lekarna as in Retailing (Czech Republic)

March 2014 | 3 pages | ID: CE7D4EFFB09EN
Euromonitor International Ltd

Abstracts

The company plans to continue to expand dynamically in the Czech Republic over the forecast period and to open approximately 30-40 Dr Max outlets per year. This expansion will be accomplished through the acquisition of existing outlets of various independent retailers as well as through opening completely new stores. The company also plans to continue to broaden its private label product range. As well as OTC products, the company also plans to start offering prescription-only medicines under...

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Non-Store Retailing, Store-based Retailing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Retailing market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Ceska lekarna as: Key Facts
Summary 2 Ceska lekarna as: Operational Indicators
Internet Strategy
Summary 3 Ceska lekarna as: Share of Sales Generated by Internet Retailing
Company Background
Private Label
Summary 4 Ceska lekarna as: Private Label Portfolio
Competitive Positioning
Summary 5 Ceska lekarna as: Competitive Position 2013